Patent ID: 9675658
Date: 2017-06-13
CPC Classifications: A23L,A61K

Claim:
1. A method of treatment comprising the administering of a pharmaceutical composition comprising a purified extract with the secondary fractionation (ATC2) from the extract of Pseudolysimachion rotundum var subintegrum , comprising 30%-60% (w/w) verproside, 0.5%-10% (w/w) veratric acid, 2%-20% (w/w) catalposide, 1%-10% (w/w) picroside II, 1%-10% (w/w) isovanilloyl catalpol and 2%-20% (w/w) 6-O-veratroyl catalpol based on the weight of total extract (100%) of Pseudolysimachion rotundum var subintegrum to a subject in need of treatment of an ailment selected from the group consisting of an inflammatory disease, an allergy disease and an asthma disease.